Global dermatology company Sesderma is expanding its presence in India as demand for evidence-based skincare continues to grow. The company is increasing engagement with dermatologists and investing in research tailored to Indian skin.
Founded by dermatologist Professor Dr Gabriel Serrano, Sesderma has built its reputation around research-driven dermatological solutions. The company plans to strengthen its India presence through professional engagement and knowledge-sharing initiatives.
Sesderma expands dermatology engagement
As part of its India expansion, Sesderma will host Grand Dermatology Symposiums across the country. The interactive events will feature Professor Dr Gabriel Serrano and focus on emerging dermatology developments.
The symposiums will cover regenerative dermatology, nanotechnology-based dermo-cosmetics and micro-needling technologies. They will also explore skin longevity, healthy skin ageing and chemical peels for Indian skin phototypes.
Serrano said research and innovation remain central to developing effective products and treatments. He also highlighted India’s diverse skin profiles and growing interest in science-backed skincare. The company sees these factors as creating opportunities for further innovation and market development in India.
Iberia Pharmaceuticals drives market expansion
Iberia Pharmaceuticals serves as Sesderma’s official and exclusive partner in India. The company is supporting Sesderma’s growth through its dermatology expertise and nationwide distribution network.
Iberia is also helping Sesderma expand beyond major metropolitan markets. Its strategy includes increasing the brand’s presence in emerging markets and Tier-II cities.
Nitin Jain, Founder and Managing Director, Iberia Pharmaceuticals, said Indian consumers increasingly seek skincare products supported by science-based formulations. He added that the partnership aims to bring advanced dermatological solutions to India’s growing skincare market.
Focus on science-backed skincare
Saurav Ojha, co-founder and full-time director at Iberia Pharmaceuticals, said the company wants to bring global dermatological science to India.
He said the symposiums will create a knowledge-exchange platform for India’s dermatology community. The events will also support greater exposure to emerging dermatological technologies and treatment approaches.
Sesderma and Iberia are responding to rising demand for science-backed skincare and clinically certified dermo-cosmetic solutions. The companies are now looking beyond India’s metropolitan markets to reach consumers in Tier-II cities. Their expansion aims to improve access to advanced dermatological skincare innovations across the country.